Primary prophylaxis with 3 weekly pegfilgrastim and ciprofloxacin effectively prevent (febrile) neutropenia and infection during neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC) in breast cancer patients

G. von Minckwitz,Ju Blohmer,A. Löhr,G. Raab,H. Eidtmann,Bernd Gerber,J. Hilfrich,J Huober,S. D. Costa,C. Jackisch,M. Kaufmann

Primary prophylaxis with 3 weekly pegfilgrastim and ciprofloxacin effectively prevent (febrile) neutropenia and infection during neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC) in breast cancer patients

2005

G. von Minckwitz
Ju Blohmer
A. Löhr
G. Raab
H. Eidtmann
Bernd Gerber
J. Hilfrich
J Huober
S. D. Costa
C. Jackisch
M. Kaufmann

8008 Background: Neutropenia and infections are frequently related with the administration of TAC (docetaxel 75mg/m2, doxorubicin 50 mg/m2, cyclophosphamide 500 mg/m2 day 1, q21). We assessed in th...

Keywords:

Breast cancer
Ciprofloxacin
Febrile neutropenia
Cyclophosphamide
Docetaxel/doxorubicin
Chemotherapy
Internal medicine
Oncology
Pegfilgrastim
Medicine
Doxorubicin
Neutropenia
Docetaxel

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations